Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Madrigal Pharmaceuticals

Biotech & Life Sciences · West Conshohocken, United States · Founded 2011 · IPO 2016 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$11B
Market cap · Apr/2026
Revenue
$287M
Latest reported FY

Investors

1 investor on Madrigal Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 1 investor entered at this stage
Bay City Capital

Global footprint

Where Madrigal Pharmaceuticals has talent and traffic

AI talent share
0.4% of workforce is AI talent
(4 of 1,071 staff)
Core AI30.28%
Other AI10.09%
Non-AI workforce1,06799.63%
Web traffic by country
140K monthly visits
across markets
🇺🇸 United States90.3%
🇬🇧 United Kingdom1.6%
🇨🇦 Canada1.4%
🇮🇳 India1.4%
🇯🇵 Japan0.9%
Top 5 markets shown

Patent intelligence

$37M patent portfolio · 53 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$37M
0.32% of market cap · 14.3× smaller than top peer ChemoCentryx ($524M)
53 active patent families
Where Madrigal Pharmaceuticals innovates DiseaseProdrugStructural formulaMedicinal chemistryInflammation
Below peer median on Legal, Strategic, Market, Technology

Quality vs same-sector peers

Madrigal Pharmaceuticals on the five Patsnap quality dimensions

Madrigal Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Madrigal Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Madrigal Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Madrigal Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo